Navitus Health Solutions
Registered Principal Details
Business Or Interest:
Navitus Health Solutions, LLC is a 100% pass-through, fully transparent, pharmacy benefit management company. Since the founding of our company in 2003, Navitus has relentlessly worked to reduce the overall drug costs paid by our clients, while improving member health, providing superior customer service, and ensuring regulatory compliance. Navitus administers pharmacy benefits for over six million members across our commercial, ACA/Exchange, Medicaid, Medicare Part D, and discount card lines of business. Based in Madison, Wisconsin, we also have a wholly-owned URAC-accredited specialty pharmacy called Lumicera Health Services.
Lobbying Interests:
Legislation, administrative rulemaking, state budgets, and other actions affecting the administration, delivery, and financing of health care services; pharmacy benefit management companies; specialty pharmacy issues; other health care issues; general business matters.
CEO Name:
David Fields
Navitus Health Solutions, LLC is a 100% pass-through, fully transparent, pharmacy benefit management company. Since the founding of our company in 2003, Navitus has relentlessly worked to reduce the overall drug costs paid by our clients, while improving member health, providing superior customer service, and ensuring regulatory compliance. Navitus administers pharmacy benefits for over six million members across our commercial, ACA/Exchange, Medicaid, Medicare Part D, and discount card lines of business. Based in Madison, Wisconsin, we also have a wholly-owned URAC-accredited specialty pharmacy called Lumicera Health Services.
Lobbying Interests:
Legislation, administrative rulemaking, state budgets, and other actions affecting the administration, delivery, and financing of health care services; pharmacy benefit management companies; specialty pharmacy issues; other health care issues; general business matters.
CEO Name:
David Fields
Contact
PP
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/15/2025
First Communication Date
4/8/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
Against
Notification Date4/15/2025
First Communication Date
4/8/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Assembly Bill 246
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
Bill Text and History
5/14/2025
First Communication Date
5/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
Bill Text and History
Other
Notification Date5/14/2025
First Communication Date
5/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 45
Relating to: state finances and appropriations, constituting the executive budget act of the 2025 legislature. (FE)
Bill Text and History
2025 Wisconsin Act 15
7/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: state finances and appropriations, constituting the executive budget act of the 2025 legislature. (FE)
Bill Text and History
2025 Wisconsin Act 15
Other
Notification Date7/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
Against
Notification Date4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 251
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
Bill Text and History
5/14/2025
First Communication Date
5/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
Bill Text and History
Other
Notification Date5/14/2025
First Communication Date
5/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Specialty Pharmacy
Specialty Pharmacy
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy Benefit Managers
Pharmacy Benefit Managers
Action Intended To Affect
Legislative matter
Notification Date
1/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
1/30/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2025 January - June |
Total | |
|---|---|---|
| Total Lobbying Expenditures | 2025 January - June $38,290.00 |
Total $38,290.00 |
| Total Hours Communicating | 2025 January - June 35.95 |
Total 35.95 |
| Total Hours Other | 2025 January - June 49.75 |
Total 49.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: state finances and appropriations, constituting the executive budget act of the 2025 legislature. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 1% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 1% |
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 2% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 2% |
Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 2% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 2% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 20% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 20% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 50% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 50% |
Budget Bill Subjects
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 15% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 15% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.